1. Notes for Guidance on the Clinical Administration of Radiopharmaceuticals and use of Sealed Radioactive Sources ARSAC, NRBP, Chilton, 1998.
2. Martensson J, Groth S, Rehling M, Gref M. Chromium-51-EDTA clearance in adults with a single-plasma sample. J Nucl Med. 1998;39:2131–7.
3. Daugaard G. Cisplatin nephrotoxicity: experimental and clinical studies. Dan Med Bull. 1990;37:1–12.
4. Hjorth L, Wiebe T, Karpman D. Correct evaluation of renal glomerular filtration rate requires clearance assays. Pediatr Nephrol. 2002;17:847–51.
5. Vorobiof DA, Iturralde M, Falkson G. Assessment of ventricular function by radionuclide angiography in patients receiving 4′-epidoxorubicin and mitoxantrone. Cancer Chemother Pharmacol. 1985;15:253–7.